Your email has been successfully added to our mailing list.

×
0 0 0 -0.0690627202255108 -0.0690627202255108 -0.0332628611698379 -0.00634249471458766 -0.0489076814658211
Analyst impact report

Proteostasis Therapeutics Inc (NASDAQ: PTI) had its "buy" rating re-affirmed by analysts at HC Wainwright.

Proteostasis Therapeutics, Inc (PTI)  More Company Research Source: MarketBeat
Last proteostasis therapeutics, inc earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview
Impact snapshot Event time: PTI
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
PTI alerts
from News Quantified
Opt-in for
PTI alerts

from News Quantified
Opt-in for
PTI alerts

from News Quantified